79272524 - ELEVECTA

Information

• Trademark
• 79272524

• Source

• Serial Number

  79272524

• Registration Number

  6110170

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 12, 2019
  4 years ago

• Registration Date

  July 28, 2020
  3 years ago

• Transaction Date

  November 19, 2023
  7 months ago

• Status Date

  July 28, 2020
  3 years ago

• Published for Opposition Date

  May 12, 2020
  4 years ago

• Location Date

  July 28, 2020
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LEE, DOUGLAS M

• Attorney Docket Number

  11168CP-10

  Attorney Name

  Miriam D. Trudell

  Law Office Assigned Location Code

  M40

• Owners

  • CEVEC Pharmaceuticals GmbH

Case File Statements

• GS0051: Medicines for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; pharmaceutical and veterinary products, preparations and reagents for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; chemical, biological and biochemical substances, preparations and reagents for medical and veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; diagnostic and analytical preparations for medical and veterinary purposes; cultures of microorganisms and viruses for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for medical or veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, for medical and veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing viral vectors, in particular vectors of adeno-associated viruses, for medical, veterinary and medical diagnostic purposes
• GS0011: Chemical, biological and biochemical reagents for scientific, research, laboratory, industrial and commercial purposes; Chemical, biological and biochemical substances and preparations for scientific, research and laboratory use; chemical, biological and biochemical substances, preparations and reagents for research use in characterizing diseases; chemical, biological and biochemical substances, preparations and reagents for scientific and medical research and drug development; chemical, biological and biochemical substances, preparations and reagents for manufacturing drugs and pharmaceuticals; cultures of microorganisms and viruses, other than for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells for scientific, research, laboratory, industrial and commercial purposes, namely, for manufacturing viral vectors, in particular vectors of adeno-associated viruses
• GS0421: Scientific and industrial research, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures, and expression systems in the nature of microorganisms, insect cells, and mammalian cells; scientific, technical and industrial research consultancy, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific laboratory services, namely, cultivation, extraction, optimization, synthesizing and modifying of eukaryotic cell lines, eukaryotic cells, in particular transfecting and selecting of eukaryotic cells and eukaryotic cell lines with a nucleic acid, in particular a plasmid, viruses, in particular adeno-associated viruses, viral vectors, in particular vectors of adeno-associated viruses, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific analysis, research and development in the nature of analysis and selection of transfected eukaryotic cells and eukaryotic cell lines and viral vectors, in particular vectors of adeno-associated viruses, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics

Case File Event Statements

• 11/19/2023 - 7 months ago

  37 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 8/21/2023 - 10 months ago

  36 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 8/21/2023 - 10 months ago

  35 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 8/21/2023 - 10 months ago

  34 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR

• 8/21/2023 - 10 months ago

  33 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/21/2023 - 10 months ago

  32 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/21/2023 - 10 months ago

  31 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 8/21/2023 - 10 months ago

  30 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 7/13/2021 - 2 years ago

  29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/13/2021 - 2 years ago

  28 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 7/13/2021 - 2 years ago

  27 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/13/2021 - 2 years ago

  26 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/11/2021 - 3 years ago

  25 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/11/2021 - 3 years ago

  24 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 6/11/2021 - 3 years ago

  23 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/11/2021 - 3 years ago

  22 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/6/2020 - 3 years ago

  21 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 11/17/2020 - 3 years ago

  20 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 11/16/2020 - 3 years ago

  19 - FINAL DISPOSITION PROCESSED Type: FIMP

• 10/28/2020 - 3 years ago

  18 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 7/28/2020 - 3 years ago

  17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/12/2020 - 4 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/12/2020 - 4 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/22/2020 - 4 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/1/2020 - 4 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/18/2020 - 4 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/17/2020 - 4 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/17/2020 - 4 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/24/2020 - 4 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/3/2020 - 4 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 1/2/2020 - 4 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/4/2019 - 4 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/3/2019 - 4 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/29/2019 - 4 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 11/26/2019 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/25/2019 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/21/2019 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR